Works matching DE "RIVASTIGMINE"

Results: 94

Rivastigmine for Cognitive Impairment in Multiple Sclerosis: A Prospective Randomized Open Label Study with Blinded End‑Point Assessment.

Published in:

Neurology India, 2023, v. 71, n. 3, p. 514, doi. 10.4103/0028-3886.378694

By:

Gotur, Amrita J.;
Prasad, Kameshwar;
Bhatia, Rohit;
Srivastava, Achal K.;
Tripathi, Manjari;
Goyal, Vinay;
Pandit, Awadh K.;
Vibha, Deepti;
Rajan, Roopa;
Srivastava, M. V. Padma

Publication type:

Article

Correction: Rivastigmine attenuates the Alzheimer's disease related protein degradation and apoptotic neuronal death signaling.

Published in:: Biochemical Journal, 2022, v. 479, n. 11, p. 1147, doi. 10.1042/BCJ20200754_COR
Publication type:: Article

Atypical Presentation of Acetylcholinesterase Inhibitor-Induced Diarrhea in Older Adults with Cognitive Decline: An Aspect not to be Underestimated.

Published in:

Annals of Geriatric Medicine & Research, 2023, v. 27, n. 1, p. 83, doi. 10.4235/agmr.22.0116

By:

Pagliuca, Raffaele;
Papa, Mario Virgilio;
Ilaria, Pagliuca Mena;
Papa, Virginia Federica;
Varricchio, Gina

Publication type:

Article

Dementia Drugs and Age-Related Macular Degeneration.

Published in:

2024

By:

Almidani, Louay;
Ramulu, Pradeep Y.

Publication type:

Opinion

Rivastigmine Improves Appetite by Increasing the Plasma Acyl/Des-Acyl Ghrelin Ratio and Cortisol in Alzheimer Disease.

Published in:

Dementia & Geriatric Cognitive Disorders, 2018, v. 8, n. 1, p. 77, doi. 10.1159/000487358

By:

Furiya, Yoshiko;
Tomiyama, Takami;
Izumi, Tesseki;
Ohba, Naoki;
Ueno, Satoshi

Publication type:

Article

Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors.

Published in:

Drug, Healthcare & Patient Safety, 2025, v. 17, p. 75, doi. 10.2147/DHPS.S506523

By:

Chikermane, Soumya G;
Li, Jieni;
Aparasu, Rajender R

Publication type:

Article

Treatment of pediatric antimuscarinic delirium with oral rivastigmine.

Published in:

Oxford Medical Case Reports, 2023, v. 2023, n. 9, p. 1, doi. 10.1093/omcr/omad096

By:

Yakey, Brandtly;
Vohra, Varun;
Martin, Amarilis;
King, Andrew M

Publication type:

Article

Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1343650

By:

Ni Zhang;
Lanlan Gan;
Guiyuan Xiang;
Jing Xu;
Tingting Jiang;
Yanping Li;
Yuanlin Wu;
Rui Ni;
Yao Liu

Publication type:

Article

Development and Characterization of Rivastigmine Hydrogen Tartrate Elementary Osmotic Tablets.

Published in:

International Journal of Pharmaceutical Investigation, 2024, v. 14, n. 1, p. 239, doi. 10.5530/ijpi.14.1.30

By:

Naz, Ayesha;
Subrahmanyam, C. V. S.;
Rachamalla, Shyam Sunder

Publication type:

Article

Analytical Method Development and Validation of Rivastigmine in its Pure and Pharmaceutical Dosage form Using UPLC.

Published in:

International Journal of Pharmaceutical Investigation, 2023, v. 13, n. 3, p. 595, doi. 10.5530/ijpi.13.3.074

By:

Kommu, Aarthi;
Sundararajan, Raja

Publication type:

Article

Alzheimer Disease.

Published in:: Psychiatric Times, 2023, v. 40, n. 3, p. 7
Publication type:: Article

Neuroprotective Effect of Valeric Acid in Combination with Piracetam and Rivastigmine by Evaluating the Expression of Caspase 3 in Alzheimer’s Disease Induced Rats.

Published in:

Frontiers in Health Informatics, 2024, v. 13, n. 7, p. 385

By:

D., Blessina Sugandhi;
S., Bindhu;
S., Nidhi;
Kumar, Shishir;
Panda, Dhiren Kumar

Publication type:

Article

A Novel Formulation: Donepezil Patch.

Published in:

Senior Care Pharmacist, 2023, v. 38, n. 7, p. 300, doi. 10.4140/TCP.n.2023.300

By:

Adelman, Megan;
Louis, Lora

Publication type:

Article

Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis.

Published in:

Advances in Clinical & Experimental Medicine, 2024, v. 33, n. 11, p. 1179, doi. 10.17219/acem/176051

By:

Yaqi Gao;
Yulin Liu;
Yanfang Li

Publication type:

Article

Rivastigmine patch and massage for Alzheimer's disease patients.

Published in:

Geriatrics & Gerontology International, 2013, v. 13, n. 2, p. 515, doi. 10.1111/ggi.12010

By:

Satoh, Sachiko;
Kajiwara, Mutsuko;
Kiyokawa, Emi;
Toukairin, Yoshiko;
Fujii, Masahiko;
Sasaki, Hidetada

Publication type:

Article

Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 631, doi. 10.1177/1352458512463481

By:

Mäurer, M;
Ortler, S;
Baier, M;
Meergans, M;
Scherer, P;
Hofmann, WE;
Tracik, F

Publication type:

Article

Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis.

Published in:

Age & Ageing, 2023, v. 52, n. 6, p. 1, doi. 10.1093/ageing/afad091

By:

Huang, Yu-Yuan;
Teng, Teng;
Giovane, Cinzia D;
Wang, Rong-Ze;
Suckling, John;
Shen, Xue-Ning;
Chen, Shi-Dong;
Huang, Shu-Yi;
Kuo, Kevin;
Cai, Wen-Jie;
Chen, Ke-Liang;
Feng, Lei;
Zhang, Can;
Liu, Cai-Yan;
Li, Chun-Bo;
Zhao, Qian-Hua;
Dong, Qiang;
Zhou, Xin-Yu;
Yu, Jin-Tai

Publication type:

Article

The Effect of the Acetylcholinesterase Inhibitor Rivastigmine on the Pentylenetetrazole-Induced Kindling Model of Experimental Epilepsy.

Published in:

Acta Physiologica, 2023, v. 237, p. 65

By:

Türkdönmez, Elif;
Okuyucu, Büşra;
Hatipoğlu, Burcu;
Tiryaki, Emre Soner;
Arslan, Gökhan;
Ağar, Erdal;
Ayyıldız, Mustafa

Publication type:

Article

The Effect of Rivastigmine on Spike-Wave Discharges and Interaction with T-Type Calcium Channels in WAG/Rij Rats.

Published in:

Acta Physiologica, 2023, v. 237, p. 34

By:

Türkdönmez, Elif;
Okuyucu, Büşra;
Tiryaki, Emre Soner;
Arslan, Gökhan;
Ağar, Erdal;
Ayyıldız, Mustafa

Publication type:

Article

Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.

Published in:

Journal of Medical Toxicology, 2023, v. 19, n. 2, p. 219, doi. 10.1007/s13181-022-00925-z

By:

Whitledge, James D.;
Watson, C. James;
Simpson, Michael;
Bakkar, Azza;
Boussi, Leora;
Scott, Michael;
Boyle, Katherine L.

Publication type:

Article

Anti-dementia medication use in Aotearoa New Zealand: An exploratory study using health data from the Integrated Data Infrastructure (IDI).

Published in:

Australian & New Zealand Journal of Psychiatry, 2023, v. 57, n. 6, p. 895, doi. 10.1177/00048674221121091

By:

Yan Chan, Amy Hai;
Hikaka, Jo anna;
To, Edith;
Cullum, Sarah;
Ma’u, Etuini;
Ryan, Brigid;
Rivera-Rodriguez, Claudia;
Cheung, Gary

Publication type:

Article

A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient.

Published in:

Australian & New Zealand Journal of Psychiatry, 2018, v. 52, n. 2, p. 204, doi. 10.1177/0004867417741983

By:

Pei-Chun Chao;
Juo-Chi Li;
Ta-Chuan Yeh;
Chin-Bin Yeh

Publication type:

Article

Rivastigmine for treatment resistant Post Traumatic stress disorder.

Published in:

Australian & New Zealand Journal of Psychiatry, 2017, v. 51, n. 9, p. 946, doi. 10.1177/0004867417698234

By:

Murray, Alexander;
Wallace, Duncan;
Nielssen, Olav

Publication type:

Article

Validated LC/MS/MS Method for the Determination of Rivastigmine in Human Plasma: Application to a Pharmacokinetic Study in Egyptian Volunteers to Determine the Effect of Gender and Body Mass Index.

Published in:

Journal of Chromatographic Science, 2023, v. 61, n. 5, p. 453, doi. 10.1093/chromsci/bmac046

By:

ElKady, Ehab F;
Mostafa, Eman A

Publication type:

Article

No interaction between rivastigmine and citalopram on memory and novelty processing in healthy human volunteers.

Published in:

2019

By:

Heckman, P. R. A.;
Blokland, A.;
Sambeth, A.;
Heckman, Pra

Publication type:

journal article

FDA-Approved Drugs to Treat Dementia.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2024, v. 62, n. 4, p. 5, doi. 10.3928/02793695-20240228-79
Publication type:: Article

Cognitive Benefit of Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.

Published in:

Neurology Alert, 2021, v. 40, n. 6, p. 1

By:

AHC MEDIA

Publication type:

Article

Concise Synthesis of Chiral Tricyclic Lactams by Tandem Dynamic Kinetic Asymmetric Reductive Amination/Lactamization Using Ammonium Salts.

Published in:

Angewandte Chemie, 2023, v. 135, n. 25, p. 1, doi. 10.1002/ange.202303868

By:

Wang, Jingxin;
Shi, Yongjie;
Wang, Fangyuan;
Huang, Fanping;
Bai, Shao‐Tao;
Zhao, Yu;
Zhang, Xumu

Publication type:

Article

Carbamate as a potential anti‐Alzheimer's pharmacophore: A review.

Published in:

Drug Development Research, 2023, v. 84, n. 8, p. 1624, doi. 10.1002/ddr.22113

By:

Singh, Yash Pal;
Kumar, Navneet;
Chauhan, Brijesh Singh;
Garg, Prabha

Publication type:

Article

Changes in Alcohol Consumption and Risk of Dementia in a Nationwide Cohort in South Korea.

Published in:

JAMA Network Open, 2023, v. 6, n. 2, p. e2254771, doi. 10.1001/jamanetworkopen.2022.54771

By:

Jeon, Keun Hye;
Han, Kyungdo;
Jeong, Su-Min;
Park, Junhee;
Yoo, Jung Eun;
Yoo, Juhwan;
Lee, Jinkook;
Kim, SangYun;
Shin, Dong Wook

Publication type:

Article

Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.953686

By:

Henstra, Marieke J.;
Feenstra, Thomas C.;
Kok, Rob M.;
Spaans, Harm-Pieter;
van Exel, Eric;
Dols, Annemiek;
Oudega, Mardien;
Vergouwen, Anton C. M.;
van der Loo, Adriano;
Bet, Pierre M.;
Loer, Stephan A.;
Eikelenboom, Merijn;
Sienaert, Pascal;
Lambrichts, Simon;
Bouckaert, Filip;
Bosmans, Judith E.;
van der Velde, Nathalie;
Beekman, Aartjan T. F.;
Stek, Max L.;
Rhebergen, Didi

Publication type:

Article

Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine.

Published in:

Advanced Pharmaceutical Bulletin, 2020, v. 10, n. 1, p. 20, doi. 10.15171/apb.2020.003

By:

Salatin, Sara;
Barar, Jaleh;
Barzegar-Jalali, Mohammad;
Adibkia, Khosro;
Alami-Milani, Mitra;
Jelvehgari, Mitra

Publication type:

Article

The effects of rivastigmine on neuropsychiatric symptoms in the early stages of Parkinson's disease: A systematic review.

Published in:

European Journal of Neurology, 2024, v. 31, n. 2, p. 1, doi. 10.1111/ene.16142

By:

Reilly, Siobhan;
Dhaliwal, Simran;
Arshad, Usman;
Macerollo, Antonella;
Husain, Nusrat;
Costa, Antonio Da

Publication type:

Article

Piracetam, Rivastigmine and Their Joint Consumption Effects on MMSE Score Status in Patients with Alzheimer's Disease.

Published in:

Iranian Journal of Pharmacology & Therapeutics, 2012, v. 11, n. 2, p. 60

By:

IRANMANESH, FARAD;
VAKILIAN, ALIREZA;
GADARI, FARANAK;
SYADI, AHMADREZA;
MEHRABIAN, MILAD;
MORADI, MARYAM;
RAESY, ELAHE

Publication type:

Article

The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.

Published in:

BMC Neurology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2377-13-188

By:

Henderson, Emily J.;
Lord, Stephen R.;
Close, Jacqueline CT;
Lawrence, Andrew D.;
Whone, Alan;
Ben-Shlomo, Yoav

Publication type:

Article

The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.

Published in:

2013

By:

Henderson, Emily J;
Lord, Stephen R;
Close, Jacqueline Ct;
Lawrence, Andrew D;
Whone, Alan;
Ben-Shlomo, Yoav;
Close, Jacqueline C T

Publication type:

journal article

The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer’s Disease.

Published in:

American Journal of Alzheimer's Disease & Other Dementias, 2018, v. 33, n. 6, p. 385, doi. 10.1177/1533317518775044

By:

Kazmierski, Jakub;
Messini-Zachou, Chaido;
Gkioka, Mara;
Tsolaki, Magda

Publication type:

Article

Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer’s Disease: Oral or Patch?

Published in:

American Journal of Alzheimer's Disease & Other Dementias, 2014, v. 29, n. 8, p. 735, doi. 10.1177/1533317514536598

By:

Isik, Ahmet Turan;
Soysal, Pinar;
Yay, Adnan

Publication type:

Article

Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on Instrumental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease.

Published in:

2013

By:

Grossberg, George;
Cummings, Jeffrey;
Frölich, Lutz;
Bellelli, Giuseppe;
Molinuevo, José L.;
Krahnke, Tillmann;
Strohmaier, Christine

Publication type:

Journal Article

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 4, p. 9, doi. 10.1002/pu.31151
Publication type:: Article

Rivastigmine ameliorates indomethacin experimentally induced gastric mucosal injury via activating α7nAChR with inhibiting oxidative stress and apoptosis.

Published in:

Journal of Biochemical & Molecular Toxicology, 2022, v. 36, n. 10, p. 1, doi. 10.1002/jbt.23147

By:

Khalaf, Hanaa M.;
Ahmed, Sabreen M.;
Welson, Nermeen N.;
Abdelzaher, Walaa Yehia

Publication type:

Article

Opposite changes in blood pressure and pulse rate in two patients with distigmine and rivastigmine intoxication.

Published in:

JA Clinical Reports, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40981-020-00323-w

By:

Sedogawa, Hiraku;
Matsuo, Mitsuhiro

Publication type:

Article

Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease.

Published in:

Neurological Sciences, 2015, v. 36, n. 3, p. 457, doi. 10.1007/s10072-014-2002-3

By:

Cagnin, Annachiara;
Cester, Alberto;
Costa, Bruno;
Ermani, Mario;
Gabelli, Carlo;
Gambina, Giuseppe

Publication type:

Article

Rivastigmine Regulates the HIF-1α/VEGF Signaling Pathway to Induce Angiogenesis and Improves the Survival of Random Flaps in Rats.

Published in:

Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.818907

By:

Liu, Yingying;
Li, Wenjie;
Ma, Xinyi;
He, Jibing;
Lin, Yi;
Lin, Dingsheng

Publication type:

Article

Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson's Disease.

Published in:

Parkinson's Disease (20420080), 2023, p. 1, doi. 10.1155/2023/6667339

By:

Rosqvist, Kristina;
Odin, Per

Publication type:

Article

Characteristics of patients with Alzheimer's disease who switch to rivastigmine transdermal patches in routine clinical practice.

Published in:

Patient Preference & Adherence, 2013, v. 7, p. 47, doi. 10.2147/PPA.S38719

By:

López-Pousa, Secundino;
Javier Arranz, Francisco

Publication type:

Article

The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs.

Published in:

PLoS ONE, 2023, v. 18, n. 6, p. 1, doi. 10.1371/journal.pone.0286386

By:

Tsianou, Chrysostomi Christina;
Kvetina, Jaroslav;
Radochova, Vera;
Kohoutova, Darina;
Rejchrt, Stanislav;
Valis, Martin;
Zdarova Karasova, Jana;
Tacheci, Ilja;
Knoblochova, Veronika;
Soukup, Ondrej;
Bures, Jan

Publication type:

Article

Donepezil as a safe alternative treatment after maculo‐papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.

Published in:

2024

By:

Chouchana, Margot;
Pinel, Sylvine;
Colboc, Hester;
Soria, Angele;
Buard, Geraldine;
Delage, Clément;
Bloch, Vanessa;
Lilamand, Matthieu

Publication type:

Case Study

The transition from vivid dreams over floccillations and visual hallucinations to complete delirium in a geriatric patient at the dawn of Alzheimer's dementia: beneficial role of rivastigmine.

Published in:

2019

By:

Bonnet, Udo;
Taha, Sarya;
Stuehler, Luidmilla;
Knierim, Uwe

Publication type:

Case Study

Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.

Published in:

Psychogeriatrics, 2013, v. 13, n. 1, p. 1, doi. 10.1111/j.1479-8301.2012.00403.x

By:

Kulkantrakorn, Kongkiat;
Tanyakitpisal, Panas;
Towanabut, Somchai;
Dejthevaporn, Charungthai;
Rangseekajee, Poonsri;
Pongpakdee, Sunsanee;
Laptikultham, Somsak;
Rodprasert, Kritsada;
Setthawatcharawanich, Suwanna;
Thinkhamrop, Bandit

Publication type:

Article